BDPC Bromadol, an recently created analgesic, exhibits unique biological properties. This compound primarily operates through the incomplete mu-opioid location agonist, also demonstrates notable action on the κ-opioid binding site as well. The mixed effect results at a complex range of effects, including analgesia, sedation, and maybe breathing